Focal Biosciences is co-founded by The Paul Scherrer Institute and Apollo Health Ventures. It will initially operate out of the Paul Scherrer Institute, the largest research institute for natural and engineering sciences in Switzerland that serves scientists around the world by accommodating highly complicated experiments in their industry-leading research facilities. Focal Biosciences thereby has access to PSI’s key infrastructure and expertise as part of Apollo’s venture creation program, “Venture Labs” that sources leading science from scientists and labs in Europe and North America, based on its deep understanding of the biology of aging.

The company develops a scalable cellular reprogramming discovery platform for interventions that restore a functional cell state in the physiological context of aging and age-related disease using novel epigenetic signatures.